Related Experiment Video

Updated: May 9, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Function of miRNA in controlling drug resistance of human cancers

Liu Hong1, Zhiping Yang, Jiaojiao Ma

  • 1State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, China.

Current Drug Targets
|July 10, 2013
PubMed

Insights

MicroRNAs are key regulators of cancer drug resistance. Harnessing these microRNAs offers new strategies for personalized cancer treatment and improved patient outcomes.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Drug resistance significantly impedes effective cancer therapy.
  • MicroRNAs are crucial post-transcriptional regulators involved in cellular processes, including drug resistance.
  • Identifying novel strategies to overcome drug resistance is vital for enhancing clinical outcomes in cancer patients.

Purpose of the Study:

  • To review recent advancements in understanding microRNAs associated with cancer drug resistance.
  • To analyze the clinical and therapeutic applications of drug resistance-related microRNAs.
  • To explore future directions for microRNA-based cancer treatment strategies.

Main Methods:

  • Comprehensive literature review of recent research on microRNAs and cancer drug resistance.
  • Analysis of clinical data and therapeutic strategies involving microRNAs.
  • Synthesis of current findings and future perspectives on microRNA applications in oncology.

Main Results:

  • MicroRNAs play a significant role in regulating cancer cell response to therapeutic drugs.
  • Specific microRNAs can serve as biomarkers for patient stratification and treatment selection.
  • Emerging therapeutic strategies leverage microRNAs to overcome or sensitize tumors to drug resistance.

Conclusions:

  • Drug resistance-related microRNAs represent a promising avenue for developing novel cancer therapies.
  • Further research is essential to translate microRNA-based strategies into successful clinical applications.
  • Personalized medicine approaches utilizing microRNAs hold potential for improving cancer treatment efficacy.

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...